At the European Association for the Study of Diabetes meeting, Louis J. Aronne, MD, argued that obesity medications could make bariatric surgery obsolete, thanks to drugs that treat multiple metabolic conditions. Francesco Rubino, MD, countered, suggesting “metabolic” surgery will continue to play a key role, especially for long-term management of obesity and related conditions. Aronne believes future treatments will address obesity earlier, while Rubino sees surgery remaining important for certain patients. Both agree obesity management is evolving rapidly.
Trending
- This is your doctor on ChatGPT (Business Insider)
- Experts’ Practices Vary in Managing Barrett Esophagus (Medscape)
- 6 Gastroenterology Headlines You Missed in October 2025 (HCP Live)
- The Clinician’s Guide to Breaking Into Digital Health (Massively Better Healthcare)
- UnitedHealthcare pays Optum doctors more than other doctors: study (Healthcare Dive)
- American Gastroenterological Association and MATTER welcome 11 startups to inaugural incubator (MATTER)
- Tri Century Eye Care & Pittsburgh Gastroenterology Associates Announce Data Breaches (The HIPAA Journal)
- Five ways for independent GI practices to prepare for payment cuts (AGA)
